
LakeShore Biopharma Amends Merger Agreement for Going-Private Transaction, Reducing Per-Share Consideration to $0.066
LakeShore Biopharma has amended its merger agreement to take the company private, reducing the per-share consideration from $0.90 to $0.066, implying an equity value of approximately US$2.7 million, amid shareholder approval and expected closure in Q3 2026.
Read full story
























